 COL-3 features a tetracycline scaffold that is unsubstituted on positions C4–C9.Advantages of CMT over conventional tetracyclines are that chronic use does not result in gastrointestinal toxicity and higher plasma levels can be achieved for extended time span reducing administration frequency.The pharmacokinetics of COL-3 has been studied in rats.